Treatment of chronic carriers of Salmonella typhi and Salmonella paratyphi B with trimethoprim-sulfamethoxazole.
D002353:Carrier State / Q000188:drug therapy* / Q000382:microbiology; D002908:Chronic Disease; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D005705:Gallbladder Diseases / Q000150:complications; D005858:Germany; D006801:Humans; D008297:Male; D010284:Paratyphoid Fever / Q000188:drug therapy* / Q000382:microbiology; D012482:Salmonella paratyphi A / Q000302:isolation & purification; D012485:Salmonella typhi / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014435:Typhoid Fever / Q000188:drug therapy* / Q000382:microbiology
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole